The 2nd Edition of International Conference on Clinical Immunology, Allergy & Autoimmune Diseases (ICIAA 2027) will take place from June 28–30, 2027, in Rome, Italy as a Hybrid Event, with both onsite and online participation available. The conference will provide a professional platform for sharing scientific research, discussing clinical developments, and supporting collaboration in clinical immunology, allergy, and autoimmune diseases. Guided by the theme “Advancing Immunology and Allergy Care through Research and Innovation”, the conference will support broad scientific exchange and professional collaboration across the field.
ICIAA 2027 welcomes immunologists, allergists, rheumatologists, clinical researchers, physicians, healthcare professionals, academicians, laboratory scientists, students, pharmaceutical experts, biotechnology professionals, and industry representatives. The conference creates opportunities to exchange expertise, establish professional connections, and discuss developments shaping immunological research and patient care.
Scientific sessions will highlight clinical immunology, allergic diseases, autoimmune disorders, immune regulation, immunotherapy, inflammatory diseases, molecular immunology, immunogenetics, allergy diagnostics, biologic therapies, transplant immunology, pediatric immunology, vaccine immunology, precision medicine, and emerging therapeutic strategies related to disease management and clinical outcomes.
The program will include keynote sessions, oral presentations, poster presentations, workshops, and networking sessions. Participants will have opportunities to present research, exchange professional insights, and connect with specialists in immunology, allergy, and autoimmune disease research.
We welcome you to join ICIAA 2027 in Rome, Italy, or online for a focused exchange on current developments in this field.
Enter the below details to download sponsorship prospectus
